Literature DB >> 10719282

Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study.

G Mazzuoli1, M Acca, D Pisani, D Diacinti, A Scarda, L Scarnecchia, M T Pacitti, E D'Erasmo, S Minisola, G Bianchi, G Manfredi.   

Abstract

The aim of this study was to establish the duration and annual rate of menopause-related bone loss and to investigate the relationship between bone turnover and bone loss in early healthy postmenopausal women. The rate of change in bone mineral density (BMD) at the lumbar spine and in bone turnover was measured twice at the exact interval of 12 months by dual-energy X-ray absorptiometry (DXA) and by the determination of plasma alkaline phosphatase levels (ALP) and fasting urinary hydroxyproline/creatinine ratio (OHPr/Cr), respectively, in 123 healthy premenopausal and postmenopausal women 45-60 years of age. The subjects were divided into nine groups according to their menstrual status and years since menopause (YSM). Annual bone loss at the lumbar spine of women who were menopausal for 1, 2, 3, 4, and 5 years was -2.62 +/- 0.37 (95% confidence interval -3.66, -1.58), -3.87 +/- 0.96 (-6.02, -1.73), -2.50 +/- 0. 37 (-3.29, -1.70), -2.86 +/- 0.73 (-4.44, -1.27), and -1.54 +/- 0.41 (-2.42, -0.66), respectively, and was significantly less than zero. But, the annual bone loss of women who were premenopausal or menopausal for 6, 7, and 8 years was -0.76 +/- 0.60 (-2.04, +0.53), -1.16 +/- 0.68 (-2.61, +0.29), 0.24 +/- 0.48 (-0.78, +1.26), and 0. 16 +/- 0.63 (-1.18, -1.49), respectively, and was not significantly different from zero. These results demonstrate that the early hormone-dependent bone loss commences in the first year after menopause and is arrested within 6 years after the onset of menopause. The overall bone loss for this phase is estimated to be approximately 15%. Annual change in ALP and OHPr/Cr seems to indicate that bone resorption prevails on bone formation in the first 2 YSM, whereas osteoblastic activity relatively prevails from YSM 3 to YSM 5, which explains the progressive repairing of the imbalance between bone resorption and formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719282     DOI: 10.1016/S8756-3282(00)00242-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

Review 1.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

2.  Effect of gender and geographic location on the expression of primary hyperparathyroidism.

Authors:  F De Lucia; S Minisola; E Romagnoli; J Pepe; C Cipriani; A Scillitani; N Parikh; D S Rao
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

Review 3.  Aromatase inhibitor-associated bone loss: clinical considerations.

Authors:  Shubham Pant; Charles L Shapiro
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Hospital based preliminary study on osteoporosis in postmenopausal women.

Authors:  V Indumati; Vidya S Patil; Rama Jailkhani
Journal:  Indian J Clin Biochem       Date:  2007-09

5.  Screening for specific biomarkers in the serum of postmenopausal osteoporosis patients using proteomic fingerprint techniques.

Authors:  Weixing Li; Chibo Liu; Haibao Wang
Journal:  Biomed Rep       Date:  2012-09-25

6.  Association between Serum Cholesterol Level and Bone Mineral Density at Lumbar Spine and Femur Neck in Postmenopausal Korean Women.

Authors:  Jeong-Ho Go; Yun-Mi Song; Joo-Hyun Park; Jae-Young Park; Yun-Ho Choi
Journal:  Korean J Fam Med       Date:  2012-05-24

7.  Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008-2010.

Authors:  Seung Joo Chon; Yun Rak Choi; Yun Ho Roh; Bo Hyon Yun; SiHyun Cho; Young Sik Choi; Byung Seok Lee; Seok Kyo Seo
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

8.  Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women.

Authors:  Chaiho Jeong; Jinyoung Kim; Yejee Lim; Jeonghoon Ha; Mee Kyoung Kim; Hyuk-Sang Kwon; Ki-Ho Song; Moo Il Kang; Ki-Hyun Baek
Journal:  J Bone Metab       Date:  2022-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.